Suppr超能文献

尼索地平的药代动力学和血流动力学效应及其与西咪替丁的相互作用。

Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.

作者信息

van Harten J, van Brummelen P, Lodewijks M T, Danhof M, Breimer D D

机构信息

Division of Pharmacology, Center for Bio-Pharmaceutical Sciences, Leiden, The Netherlands.

出版信息

Clin Pharmacol Ther. 1988 Mar;43(3):332-41. doi: 10.1038/clpt.1988.40.

Abstract

Pharmacokinetics, diastolic blood pressure, and heart rate after oral and intravenous nisoldipine were studied in eight healthy subjects without and with cotreatment of cimetidine in a four-way crossover design. After intravenous infusion, elimination half-life (t1/2) was 4.0 +/- 2.3 hours, systemic clearance (CL) was 0.83 +/- 0.17 L/min, and volume of distribution was 1.6 +/- 0.6 L/kg. After oral nisoldipine, t1/2 was 3.8 +/- 1.3 hours and systemic availability was 3.9% +/- 3.5%. During cimetidine, t1/2 and CL were not different. Systemic availability increased to 5.7% +/- 2.8%. After all nisoldipine treatments a significant decrease in supine diastolic blood pressure (mean 10% to 16%) and increase in heart rate (mean 22% to 44%) were observed. Hemodynamic effects until 2 hours after nisoldipine administration could be fitted to a sigmoidal Emax model. At times after 2 hours a second effect peak was observed. Cimetidine inhibits the metabolism of nisoldipine but has no significant influence on hemodynamic parameters.

摘要

在一项四交叉设计中,对8名健康受试者进行了研究,观察口服和静脉注射尼索地平后的药代动力学、舒张压和心率,这些受试者分为未接受西咪替丁联合治疗组和接受西咪替丁联合治疗组。静脉输注后,消除半衰期(t1/2)为4.0±2.3小时,全身清除率(CL)为0.83±0.17L/分钟,分布容积为1.6±0.6L/kg。口服尼索地平后,t1/2为3.8±1.3小时,全身生物利用度为3.9%±3.5%。在使用西咪替丁期间,t1/2和CL没有差异。全身生物利用度增加到5.7%±2.8%。在所有尼索地平治疗后,观察到仰卧位舒张压显著降低(平均10%至16%),心率增加(平均22%至44%)。尼索地平给药后2小时内的血流动力学效应可拟合为S形Emax模型。在2小时后的时间点观察到第二个效应峰值。西咪替丁抑制尼索地平的代谢,但对血流动力学参数没有显著影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验